Rudebeck, C. J., Fornecker, L. M., Guffroy, B., Fouillet, L., Chauchet, A., Caillet, A., Gros, F.-X., Brisou, G., Manjra, H., Camus, V., Guidez, S., Claves, F., Beauvais, D., Idlhaj, M., Golfier, C., Safar, V., Ferrant, E., Bachy, E., Ghesquieres, H. and Sesques, P. (2020) “Outcomes of ibrutinib plus lenalidomide combination in patients with large B-cell lymphoma refractory to or relapsing after CAR-T-cell therapy and who failed or were ineligible for bispecific antibodies: a multicenter real-world REALI-T study”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.300868.